Related Experiment Videos
Normal values and evaluation of forced end-expiratory flow.
The American Review of Respiratory Disease
|June 1, 1975
Summary
A new spirometric measurement, forced end-expiratory flow (FEF75-85%), effectively detects early obstructive pulmonary disease in smokers and patients. This simple ventilatory test shows significant differences compared to other measures.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
- Diagnostic Spirometry
Background:
- Spirometry is crucial for assessing lung function.
- Identifying sensitive markers for early detection of obstructive lung diseases is essential.
- Existing measures like forced mid-expiratory flow (FEF25-75%) have limitations in early disease detection.
Purpose of the Study:
- To evaluate the utility of forced end-expiratory flow (FEF75-85%) as a novel spirometric measurement for detecting early obstructive pulmonary disease.
- To compare the performance of FEF75-85% with FEF25-75% in relation to age, height, smoking status, and disease presence.
Main Methods:
- Conducted spirometry on 803 healthy adults to establish prediction formulas for FEF75-85%.
- Compared FEF75-85% and FEF25-75% in smokers vs. non-smokers and in patients with peripheral airway disease.
- Assessed the diagnostic value of FEF75-85% using predicted values and standard error of estimate.
Main Results:
- FEF75-85% demonstrated a negative correlation with age and a positive correlation with height.
- FEF75-85% significantly differentiated smokers from non-smokers, unlike FEF25-75%.
- In patients with peripheral airway disease, FEF75-85% was markedly reduced compared to predicted values, showing greater sensitivity than FEF25-75%.
Conclusions:
- FEF75-85% is a sensitive spirometric parameter for detecting early obstructive pulmonary disease.
- This measurement shows greater diagnostic value in identifying smokers and patients with airway obstruction compared to FEF25-75%.
- FEF75-85% is proposed as a simple and effective ventilatory test for screening populations for early lung disease.